Over 90 Total Lots Up For Auction at One Location - WA 04/08

Cerner to work with DrFirst to connect to state prescription drug monitoring programs

Press releases may be edited for formatting or style | May 14, 2019 Health IT
KANSAS CITY, Mo., May 14, 2019 (GLOBE NEWSWIRE) -- Cerner (CERN), a global health platform and innovation company, and DrFirst, a leading provider of medication management and data solutions, are working together on a new and innovative offering to help providers tackle the opioid epidemic. By streamlining the connection from a person's electronic health record (EHR) to each state's prescription drug monitoring program (PDMP) database, physicians will have nationwide access to patient prescription drug information.

With DrFirst, Cerner will be able to connect the EHR to PDMPs in 46 states and Washington, D.C., with other states expected as they become available. Prescription drug and dispensed information collected in these state-specific databases are used to inform safer prescribing, support drug education efforts, research drug addiction and prevent substance use disorder. Assisting physicians to more effectively and efficiently connect to PDMPs helps support safer pain management, identify and mitigate risk factors and more easily manage populations at high risk for substance use disorder.

"Access to prescription drug data within and across state lines can help identify and prevent drug-seeking behaviors, as well as inform physicians of a person's history to help avoid misuse and guide treatment decisions," said Eva Karp, senior vice president and chief clinical and patient safety officer, Cerner. "At a time when the opioid epidemic continues to grow, it's important that we transform health care for the patient, advancing smarter pain management and timely engagement with individuals to prevent or alleviate substance use disorder. Our work with DrFirst to expedite connections to PDMPs is part of our ongoing commitment to relentlessly seek breakthrough innovation to shape the health care of tomorrow."
stats
DOTmed text ad

Reveal Mobi Pro now available for sale in the US

Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.

stats
For more than a decade, Cerner has been working to curb the opioid epidemic, engaging with health systems and providers to track and address opioid abuse and misuse. In 2018, Cerner announced its continued commitment to safer pain management with its Opioid Toolkit, a suite of advancements to help hospitals and health systems win the battle against the opioid epidemic. Working with DrFirst is another extension of Cerner's pledge to deliver better health experiences and outcomes, helping physicians support safe prescribing and mitigate substance use disorder.

"At DrFirst, we have long believed in the importance of connecting prescription drug monitoring data across the country and aggregating opioid-related data for clinicians to use in a standardized in-workflow user experience. We're confident that this collaboration with Cerner will be hugely impactful for providers as they strive to make use of all relevant data to inform care decisions," said G. Cameron Deemer, president, DrFirst. "Simplifying clinical workflows helps clinicians quickly review information to support treatment decisions and patient safety. We are proud to work with Cerner to support smarter prescribing and patient safety."

You Must Be Logged In To Post A Comment